These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 16723360)

  • 21. [Pars plana vitrectomy and intravitreal triamcinolone for chronic pseudophakic cystoid macular edema].
    Bencić G; Vatavuk Z; Mandić Z
    Acta Med Croatica; 2006; 60(2):93-6. PubMed ID: 16848195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Combined pharmacosurgery as treatment for diabetic macular edema: core pars plana vitrectomy and intravitreal injection of bevacizumab and triamcinolone].
    Naser H; Koss MJ; Singh P; Koch F
    Klin Monbl Augenheilkd; 2011 Oct; 228(10):910-4. PubMed ID: 21997827
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pars plana vitrectomy versus immunomodulatory therapy for intermediate uveitis: a prospective, randomized pilot study.
    Quinones K; Choi JY; Yilmaz T; Kafkala C; Letko E; Foster CS
    Ocul Immunol Inflamm; 2010 Oct; 18(5):411-7. PubMed ID: 20735289
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dexamethasone intravitreal implant for treatment of uveitic persistent cystoid macular edema in vitrectomized patients.
    Adán A; Pelegrín L; Rey A; Llorenç V; Mesquida M; Molins B; Ríos J; Keller J
    Retina; 2013; 33(7):1435-40. PubMed ID: 23514796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immune modulator therapy compared with vitrectomy for management of complicated intermediate uveitis: a prospective, randomized clinical study.
    Shalaby O; Saeed A; Elmohamady MN
    Arq Bras Oftalmol; 2020; 83(5):402-409. PubMed ID: 33084818
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and efficacy of intravitreal triamcinolone for cystoid macular oedema in uveitis.
    Young S; Larkin G; Branley M; Lightman S
    Clin Exp Ophthalmol; 2001 Feb; 29(1):2-6. PubMed ID: 11272779
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pars plana vitrectomy in diabetic macular edema.
    Micelli Ferrari T; Cardascia N; Durante G; Vetrugno M; Cardia L
    Doc Ophthalmol; 1999; 97(3-4):471-4. PubMed ID: 10896366
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medical treatment of macular edema in patients with uveitis.
    Rojas B; Zafirakis P; Christen W; Markomichelakis NN; Foster CS
    Doc Ophthalmol; 1999; 97(3-4):399-407. PubMed ID: 10896356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcome of intravitreal triamcinolone acetonide in postoperative cystoid macular oedema.
    Konstantopoulos A; Williams CP; Luff AJ
    Eye (Lond); 2008 Feb; 22(2):219-22. PubMed ID: 17016463
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pars plana vitrectomy and combination therapy pars plana vitrectomy, intravitreal triamcinolon acetonid and macular lasercoagulation - one year results].
    Stefaničková J; Strmeň P; Vavrová K; Mrózová L; Krásnik V
    Cesk Slov Oftalmol; 2012 Nov; 68(5):180-8. PubMed ID: 23461369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic diabetic macular oedema, pars plana vitrectomy or combination of PPV and laser?
    Synek S; Synkova M
    Coll Antropol; 2008 Oct; 32 Suppl 2():11-4. PubMed ID: 19137999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravitreal triamcinalone acetonide for refractory uveitic cystoid macular oedema: longterm management and outcome.
    Angunawela RI; Heatley CJ; Williamson TH; Spalton DJ; Graham EM; Antcliffe RJ; Stanford MR
    Acta Ophthalmol Scand; 2005 Oct; 83(5):595-9. PubMed ID: 16187999
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Vitrectomy with peeling retinal limiting membrane (ILM) in eyes with diabetic macular edema].
    Oficjalska-Młyńczak J; Jamrozy-Witkowska A; Muzyka-Woźniak M; Turno-Krecicka A; Gołebiowska B
    Klin Oczna; 2006; 108(7-9):273-7. PubMed ID: 17290822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pars plana vitrectomy as anti-inflammatory therapy for intermediate uveitis in children].
    Figueroa MS; Noval S; Contreras I; Arruabarrena C; García-Pérez JL; Sales M; Gil-Cazorla R
    Arch Soc Esp Oftalmol; 2010 Dec; 85(12):390-4. PubMed ID: 21354506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pars plana vitrectomy with internal limiting membrane peeling for diabetic macular edema.
    Hartley KL; Smiddy WE; Flynn HW; Murray TG
    Retina; 2008 Mar; 28(3):410-9. PubMed ID: 18327132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intraocular methotrexate in the treatment of uveitis and uveitic cystoid macular edema.
    Taylor SR; Habot-Wilner Z; Pacheco P; Lightman SL
    Ophthalmology; 2009 Apr; 116(4):797-801. PubMed ID: 19344827
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pars plana vitrectomy, internal limiting membrane peeling, and panretinal endophotocoagulation for macular edema secondary to central retinal vein occlusion.
    DeCroos FC; Shuler RK; Stinnett S; Fekrat S
    Am J Ophthalmol; 2009 Apr; 147(4):627-633.e1. PubMed ID: 19193361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparison of pars plana vitrectomy with ILM peeling and intravitreal triamcinolone in diffuse diabetic macular oedema].
    Khurieva-Sattler E; Krause M; Löw U; Gatzioufas Z; Toropygin S; Seitz B; Ruprecht K; Hille K
    Klin Monbl Augenheilkd; 2010 Jun; 227(6):496-500. PubMed ID: 20221984
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Tolerability and short-term efficacy of the Ozurdex® dexamethasone intravitreal implant for treatment of uveitic cystoid macular edema: A retrospective study of 52 injections performed at the Clermont-Ferrand teaching hospital].
    Bernard Y; Bonnin N; Farguette F; Chiambaretta F
    J Fr Ophtalmol; 2016 Jan; 39(1):1-4. PubMed ID: 26616298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pars plana vitrectomy for vitreous opacity associated with ocular sarcoidosis resistant to medical treatment.
    Ieki Y; Kiryu J; Kita M; Tanabe T; Tsujikawa A; Yamashiro K; Miyamoto N; Miura S; Honda Y
    Ocul Immunol Inflamm; 2004 Mar; 12(1):35-43. PubMed ID: 15209462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.